Verastem Inc (VSTM) concluded trading on Wednesday at a closing price of $4.85, with 5.31 million shares of worth about $25.75 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 30.73% during that period and on July 02, 2025 the price saw a gain of about 13.05%. Currently the company’s common shares owned by public are about 51.49M shares, out of which, 48.90M shares are available for trading.
Stock saw a price change of 12.79% in past 5 days and over the past one month there was a price change of -19.44%. Year-to-date (YTD), VSTM shares are showing a performance of 62.75% which decreased to -6.19% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.10 but also hit the highest price of $9.10 during that period. The average intraday trading volume for Verastem Inc shares is 2.01 million. The stock is currently trading -7.27% below its 20-day simple moving average (SMA20), while that difference is down -25.23% for SMA50 and it goes to -7.55% lower than SMA200.
Verastem Inc (NASDAQ: VSTM) currently have 51.49M outstanding shares and institutions hold larger chunk of about 69.42% of that.
The stock has a current market capitalization of $266.50M and its 3Y-monthly beta is at 0.80. It has posted earnings per share of -$3.19 in the same period. It has Quick Ratio of 3.50. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VSTM, volatility over the week remained 9.62% while standing at 7.16% over the month.
Stock’s fiscal year EPS is expected to rise by 21.10% while it is estimated to increase by 24.55% in next year. EPS is likely to shrink at an annualized rate of 27.29% for next 5-years, compared to annual growth of 31.36% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on April 10, 2025 offering a Buy rating for the stock and assigned a target price of $15 to it. Coverage by H.C. Wainwright stated Verastem Inc (VSTM) stock as a Buy in their note to investors on March 24, 2025, suggesting a price target of $10 for the stock. On December 31, 2024, BTIG Research Reiterated their recommendations, while on September 30, 2024, Guggenheim Initiated their ratings for the stock with a price target of $13. Stock get a Buy rating from BTIG Research on November 21, 2023.
